Surgepays Q2 2024 GAAP EPS $(0.66) Down From $0.40 YoY, Sales $15.086M Miss $15.154M Estimate
Portfolio Pulse from Benzinga Newsdesk
Surgepays (NASDAQ:SURG) reported a significant decline in its Q2 2024 financial performance, with a GAAP EPS of $(0.66), down 265% from $0.40 YoY, and sales of $15.086M, missing the $15.154M estimate and down 57.96% YoY.
August 13, 2024 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Surgepays reported a significant decline in Q2 2024 financial performance, with a GAAP EPS of $(0.66), down 265% YoY, and sales of $15.086M, missing the $15.154M estimate and down 57.96% YoY.
The significant decline in both EPS and sales, along with missing analyst estimates, is likely to negatively impact Surgepays' stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100